Published in Clin Gastroenterol Hepatol on November 01, 2006
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Classification and management of refractory coeliac disease. Gut (2010) 1.48
Celiac disease and persistent symptoms. Clin Gastroenterol Hepatol (2010) 0.81
Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma. Clin Gastroenterol Hepatol (2010) 0.77
Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry. Aliment Pharmacol Ther (2016) 0.77
Effect of Rothia mucilaginosa enzymes on gliadin (gluten) structure, deamidation, and immunogenic epitopes relevant to celiac disease. Am J Physiol Gastrointest Liver Physiol (2014) 0.77
Clinical-Pathological Conference Series from the Medical University of Graz : Case No 156: 82-year-old woman with chronic diarrhea and weight loss of 20 kilograms. Wien Klin Wochenschr (2015) 0.75
Severe refractory coeliac disease with response only to parenteral nutrition. Case Rep Gastroenterol (2014) 0.75
Open-Capsule Budesonide for Refractory Celiac Disease. Am J Gastroenterol (2017) 0.75
Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol (2006) 2.04
Celiac disease. N Engl J Med (2007) 10.98
The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity (2009) 8.95
Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity (2008) 6.49
The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60
A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity (2004) 3.76
Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology (2003) 3.05
Capsule endoscopy or push enteroscopy for first-line exploration of obscure gastrointestinal bleeding? Gastroenterology (2006) 2.54
Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin Gastroenterol Hepatol (2008) 2.50
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology (2008) 2.39
Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut (2007) 2.34
Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease. Gastroenterology (2005) 2.11
Inhibition of TGF-beta signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology (2006) 2.01
Prospective, randomized comparison of two small-bowel capsule endoscopy systems in patients with obscure GI bleeding. Gastrointest Endosc (2011) 1.99
Refractory coeliac disease. Best Pract Res Clin Gastroenterol (2005) 1.61
T84-intestinal epithelial exosomes bear MHC class II/peptide complexes potentiating antigen presentation by dendritic cells. Gastroenterology (2007) 1.60
A Bifidobacterium probiotic strain and its soluble factors alleviate chloride secretion by human intestinal epithelial cells. J Nutr (2009) 1.60
The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol (2010) 1.50
In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J Biol Chem (2004) 1.49
Pediatric ulcerative colitis associated with autoimmune diseases: a distinct form of inflammatory bowel disease? Inflamm Bowel Dis (2012) 1.46
Study of the impact of liver transplantation on the outcome of intestinal grafts in children. Transplantation (2006) 1.44
Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol (2011) 1.43
Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med (2007) 1.43
The European experience with double-balloon enteroscopy: indications, methodology, safety, and clinical impact. Gastrointest Endosc (2005) 1.41
A bacterial enzyme to treat celiac disease? J Pediatr Gastroenterol Nutr (2003) 1.38
Dissecting the genetic components of adaptation of Escherichia coli to the mouse gut. PLoS Genet (2007) 1.37
Alterations of the intestinal transport and processing of gliadin peptides in celiac disease. Gastroenterology (2003) 1.33
Celiac disease: an immunological jigsaw. Immunity (2012) 1.33
Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol (2007) 1.31
IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis. J Clin Invest (2010) 1.28
Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene. Gastroenterology (2007) 1.23
Restricted microbiota and absence of cognate TCR antigen leads to an unbalanced generation of Th17 cells. J Immunol (2010) 1.19
Pathomechanisms in celiac disease. Best Pract Res Clin Gastroenterol (2005) 1.18
Mechanisms involved in alleviation of intestinal inflammation by bifidobacterium breve soluble factors. PLoS One (2009) 1.15
Reduced expression of FOXP3 and regulatory T-cell function in severe forms of early-onset autoimmune enteropathy. Gastroenterology (2010) 1.15
IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J Immunol (2009) 1.12
Interleukin-15-dependent NKp46+ innate lymphoid cells control intestinal inflammation by recruiting inflammatory monocytes. Immunity (2012) 1.12
Host interactions with Segmented Filamentous Bacteria: an unusual trade-off that drives the post-natal maturation of the gut immune system. Semin Immunol (2013) 1.12
Intestinal permeability in coeliac disease: insight into mechanisms and relevance to pathogenesis. Gut (2011) 1.08
Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome. Clin Gastroenterol Hepatol (2005) 1.05
Implication of TNF-related apoptosis-inducing ligand in inflammatory intestinal epithelial lesions. Gastroenterology (2006) 1.04
Impaired control of effector T cells by regulatory T cells: a clue to loss of oral tolerance and autoimmunity in celiac disease? Am J Gastroenterol (2011) 1.03
Fetal intestinal obstruction induces alteration of enteric nervous system development in human intestinal atresia. Pediatr Res (2004) 1.02
Trade-off between bile resistance and nutritional competence drives Escherichia coli diversification in the mouse gut. PLoS Genet (2011) 1.01
Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides. Gastroenterology (2012) 1.00
Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group. Inflamm Bowel Dis (2013) 0.99
Enteropathy associated T cell lymphoma in celiac disease: a large retrospective study. Dig Liver Dis (2013) 0.99
Oral proteases: a new approach to managing coeliac disease. Gut (2006) 0.97
Genetic characterization of congenital tufting enteropathy: epcam associated phenotype and involvement of SPINT2 in the syndromic form. Hum Genet (2013) 0.96
Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology (2003) 0.96
Differential nucleocytoplasmic trafficking between the related endocytic proteins Eps15 and Eps15R. J Biol Chem (2002) 0.95
Refractory celiac disease: from bench to bedside. Semin Immunopathol (2012) 0.95
Paracellular versus transcellular intestinal permeability to gliadin peptides in active celiac disease. Am J Pathol (2011) 0.93
A founder effect at the EPCAM locus in Congenital Tufting Enteropathy in the Arabic Gulf. Eur J Med Genet (2011) 0.93
Duodenal gangliocytic paraganglioma with lymph node metastasis and an 8-year follow-up: a case report. Eur J Gastroenterol Hepatol (2012) 0.92
Factors associated with adenoma detection rate and diagnosis of polyps and colorectal cancer during colonoscopy in France: results of a prospective, nationwide survey. PLoS One (2013) 0.90
Enteropathy-associated T-cell lymphoma complicating an autoimmune enteropathy. Gastroenterology (2012) 0.89
Is refractory celiac disease more severe in old Europe? Am J Gastroenterol (2011) 0.89
Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin Gastroenterol Hepatol (2004) 0.87
Genome Sequence of "Candidatus Arthromitus" sp. Strain SFB-Mouse-NL, a Commensal Bacterium with a Key Role in Postnatal Maturation of Gut Immune Functions. Genome Announc (2014) 0.86
Food allergens are protected from degradation during CD23-mediated transepithelial transport. Int Arch Allergy Immunol (2004) 0.86
Multicenter comparison of double-balloon enteroscopy and spiral enteroscopy. J Gastroenterol Hepatol (2013) 0.86
Role of microbiota in postnatal maturation of intestinal T-cell responses. Curr Opin Gastroenterol (2011) 0.85
Yersinia pseudotuberculosis disrupts intestinal barrier integrity through hematopoietic TLR-2 signaling. J Clin Invest (2012) 0.84
Resistance to exogenous TGF-β effects in patients with systemic lupus erythematosus. J Clin Immunol (2011) 0.84
Innate T cell responses in human gut. Semin Immunol (2009) 0.84
Diagnostic yield of capsule endoscopy in refractory celiac disease. Am J Gastroenterol (2012) 0.84
Large granular lymphocytic leukemia: a treatable form of refractory celiac disease. Gastroenterology (2012) 0.83
Refractory celiac disease. Expert Rev Gastroenterol Hepatol (2014) 0.82
Refractory celiac disease. Gastrointest Endosc Clin N Am (2012) 0.82
Adulthood-onset celiac disease is associated with intercellular adhesion molecule-1 (ICAM-1) gene polymorphism. Hum Immunol (2006) 0.82
Interleukin-15, a master piece in the immunological jigsaw of celiac disease. Dig Dis (2015) 0.81
A new rat model of prenatal bowel obstruction: development and early assessment. J Pediatr Surg (2010) 0.81
The cytokine interleukin 21: a new player in coeliac disease? Gut (2008) 0.80
Specific IgG response against Mycobacterium avium paratuberculosis in children and adults with Crohn's disease. PLoS One (2013) 0.80
Coeliac disease: an update on facts and questions based on the 10th International Symposium on Coeliac Disease. J Pediatr Gastroenterol Nutr (2003) 0.80
Small bowel polypectomy by double balloon enteroscopy: Correlation with prior capsule endoscopy. World J Gastrointest Endosc (2013) 0.79
Clinical impact of push enteroscopy in patients with gastrointestinal bleeding of unknown origin. Clin Gastroenterol Hepatol (2004) 0.79
Role of intraoperative enteroscopy in the management of obscure gastointestinal bleeding at the time of video-capsule endoscopy. Am J Surg (2009) 0.79
Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome. J Pediatr Gastroenterol Nutr (2017) 0.79
Therapy in RCDII: Rationale for Combination Strategies? Dig Dis (2015) 0.78
Prenatal intestinal obstruction affects the myenteric plexus and causes functional bowel impairment in fetal rat experimental model of intestinal atresia. PLoS One (2013) 0.78